S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

CropEnergies Stock Forecast, Price & News

+0.16 (+1.36%)
(As of 11/25/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
68,567 shs
Average Volume
Market Capitalization
$1.04 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CE2 News and Ratings via Email

Sign-up to receive the latest news and ratings for CropEnergies and its competitors with MarketBeat's FREE daily newsletter.

CropEnergies logo

About CropEnergies

CropEnergies AG manufactures and distributes bioethanol, and other biofuels and related products produced from grain or other agricultural raw materials in Germany and internationally. The company also produces and sells protein food and animal feed products, including ProtiGrain, a protein animal feed for various types of livestock and pets; wheat gluten for food and animal feed; animal feed from the stillage; and ProtiWanze, a liquid animal feed for cattle and pigs. In addition, it offers liquefied carbon dioxide; and produces neutral alcohol for beverage, food, cosmetics, and pharmaceutical industries, as well as for industrial applications. The company was founded in 2006 and is headquartered in Mannheim, Germany. CropEnergies AG is a subsidiary of Südzucker AG.


CropEnergies (ETR:CE2) Stock Price Up 0.3%
November 18, 2021 |  americanbankingnews.com
The Corona Effect, Part 2
April 26, 2020 |  finance.yahoo.com
AT&T CEO Joins Disney's in Stepping Aside Mid-Makeover
April 24, 2020 |  finance.yahoo.com
AT&T announces John Stankey will become CEO on July 1
April 24, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Oil & Gas Integrated
Year Founded

Sales & Book Value

Annual Sales
$897.17 million
Cash Flow
€0.33 per share
Book Value
€6.69 per share


Pretax Margin




Free Float
Market Cap
$1.04 billion
Not Optionable

Company Calendar

Next Earnings (Estimated)


Overall MarketRank

1.36 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

CropEnergies (ETR:CE2) Frequently Asked Questions

Is CropEnergies a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CropEnergies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CropEnergies stock.
View analyst ratings for CropEnergies
or view top-rated stocks.

How has CropEnergies' stock been impacted by Coronavirus?

CropEnergies' stock was trading at €8.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CE2 stock has increased by 45.9% and is now trading at €11.92.
View which stocks have been most impacted by COVID-19

When is CropEnergies' next earnings date?

CropEnergies is scheduled to release its next quarterly earnings announcement on Wednesday, January 12th 2022.
View our earnings forecast for CropEnergies

Is CropEnergies a good dividend stock?

CropEnergies pays an annual dividend of €0.35 per share and currently has a dividend yield of 2.77%. The dividend payout ratio of CropEnergies is 43.42%. This payout ratio is at a healthy, sustainable level, below 75%.

Who are CropEnergies' key executives?

CropEnergies' management team includes the following people:
  • Dr. Stephan Meeder, CEO, CFO & Member of Exec. Board (Age 51)
  • Dr. Fritz Georg von Graevenitz, Chief Sales Officer & Member of Exec. Board (Age 44)
  • Mr. Jurgen Bottcher, Chief Technical Officer & Member of Exec. Board (Age 59)

What other stocks do shareholders of CropEnergies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CropEnergies investors own include AbbVie (ABBV), Abiomed (ABMD), Catalent (CTLT), Dynavax Technologies (DVAX), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX) and ARCA biopharma (ABIO).

What is CropEnergies' stock symbol?

CropEnergies trades on the ETR under the ticker symbol "CE2."

What is CropEnergies' stock price today?

One share of CE2 stock can currently be purchased for approximately €11.92.

How much money does CropEnergies make?

CropEnergies has a market capitalization of $1.04 billion and generates $897.17 million in revenue each year.

How many employees does CropEnergies have?

CropEnergies employs 450 workers across the globe.

What is CropEnergies' official website?

The official website for CropEnergies is www.cropenergies.com.

How can I contact CropEnergies?

The company can be reached via phone at 49 621 71 41 9000.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.